Lilly - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

FDA follows EMA in halting prescriptions of Lilly’s Lartruvo

Results from Lilly’s Phase III trial into Lartruvo demonstrated it didn’t show an improvement in overall survival compared to the standard of care. Credit: Shutterstock.